HCPLive Network

Single-Question Patient Survey Can Accurately Assess Low Back Pain Severity

 
single-question low back pain surveyMONDAY, Feb. 4 (HealthDay News) -- Patient-reported chronic low-back pain (CLBP) severity, based on answering a single question, provides an accurate indicator of patient-reported health status, according to a study published in the February issue of the Journal of Spinal Disorders & Techniques.

Alesia B. Sadosky, Ph.D., M.P.H., M.B.A., from Global Health Economics and Outcomes Research at Pfizer Inc. in New York City, and colleagues analyzed data from the 2009 Adelphi Disease Specific Programme, in which patients reported the severity of their CLBP condition by answering a single question: "Please rate how your CLBP condition is today." Patient reported severity (mild, moderate, or severe) was assessed with respect to scores on standard patient self-report measures of pain and function.

The researchers found that, of the 1,363 survey respondents (49 percent male; mean age, 54.8 years; 52 percent employed at least part time), 28.6, 53.3, and 18.2 percent, respectively, reported mild, moderate, and severe CLBP. As the severity of CLBP increased, there were significant differences observed in increased pain, pain interference with function, and CLBP-linked impairment while working, mainly due to presenteeism. There were higher costs related to lost work productivity resulting from increased work impairment, with estimated annual lost productivity costs of $7,080 per patient for mild CLBP, $16,616 for moderate CLBP, and $25,032 for severe CLBP. CLBP severity was inversely associated with patient satisfaction with pain-related medication.

"The association between patient-reported CLBP severity and other patient-reported outcomes demonstrates that in the clinical setting, patient-reported CLBP severity provides an accurate and suitable indicator of patient-reported health status," the authors write.

Several authors are employed by or disclosed financial ties to Pfizer and Adelphi. The study was supported by Pfizer.

Abstract
Full Text (subscription or payment may be required)


Copyright © 2013 HealthDay. All rights reserved.
 
 

Further Reading
A new implantable eye device might make reading glasses a thing of the past, according to research presented at the annual meeting of the American Academy of Ophthalmology, held from Oct. 18 to 21 in Chicago.
Interim study results presented at ACG 2014 indicate that treatment with vedolizumab safely and effectively maintains long-term clinical remission and response in patients with Crohn’s disease and ulcerative colitis.
A man's caffeine intake could hamper the success of a couple's infertility treatment, while mild alcohol use by would-be fathers might help boost the odds of pregnancy through in vitro fertilization (IVF), according to research presented at the annual meeting of the American Society for Reproductive Medicine, held from Oct. 18 to 22 in Honolulu.
A child receives the wrong medication or the wrong dosage every 8 minutes in the United States, according to a study published online Oct. 20 in Pediatrics.
A three-minute diagnostic assessment (3D-Confusion Assessment Method) has high sensitivity and specificity for identifying delirium, according to a study published in the Oct. 21 issue of the Annals of Internal Medicine.
In the era of rapidly improving cure rates for hepatitis C infection, has the importance of staging as part of treatment diminished?
Study results show that patients suffering from active inflammatory bowel disease (IBD) are at risk for poor prognoses following an initial myocardial infarction.
More Reading